Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML

Clinical trial NCT03904069 · WITHDRAWN

Trial details

NCT number: NCT03904069
Sponsor: Amgen
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Acute Myeloid Leukemia

Start date: 2023-03-13
Primary completion: 2030-08-07
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.